Veschetti, L.; Sandri, A.; Krogh Johansen, H.; Lleò, M.M.; Malerba, G.
Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection. Pathogens 2020, 9, 72.
https://doi.org/10.3390/pathogens9020072
AMA Style
Veschetti L, Sandri A, Krogh Johansen H, Lleò MM, Malerba G.
Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection. Pathogens. 2020; 9(2):72.
https://doi.org/10.3390/pathogens9020072
Chicago/Turabian Style
Veschetti, Laura, Angela Sandri, Helle Krogh Johansen, Maria M. Lleò, and Giovanni Malerba.
2020. "Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection" Pathogens 9, no. 2: 72.
https://doi.org/10.3390/pathogens9020072
APA Style
Veschetti, L., Sandri, A., Krogh Johansen, H., Lleò, M. M., & Malerba, G.
(2020). Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection. Pathogens, 9(2), 72.
https://doi.org/10.3390/pathogens9020072